Physician profile
Ryan Klein
NPI 1184620866
$78,398.71
in general payments reported to CMS, 2019-2025
82 companies · $3,554 in 2025
The $3,554 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $3,309 · 2021: $10K · 2022: $8,345 · 2023: $13K · 2024: $3,732 · 2025: $3,554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,250 · Travel and Lodging: $2,408 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,061.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,250.00 |
| Travel and Lodging | $2,408.35 |
| Education | $188.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $25,534.03 | 2019-2025 | Trelegy Ellipta, Nucala, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $16,205.65 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,424.19 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| Genzyme Corporation | $6,286.13 | 2019-2025 | |
| Sunovion Pharmaceuticals INC. | $3,433.21 | 2019 | |
| Genentech USA, INC. | $1,835.38 | 2019-2023 | Xolair |
| Regeneron Healthcare Solutions, INC. | $1,501.35 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $1,480.51 | 2019-2025 | Prolastin-C Liquid |
| Abbvie INC. | $1,432.34 | 2021-2025 | |
| Amgen INC. | $1,384.55 | 2019-2025 | Evenity, Tezspire, Prolia |
| Novartis Pharmaceuticals Corporation | $1,011.52 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $969.95 | 2021-2025 | Hyqvia, Cuvitru, Glassia |
| Pfizer INC. | $721.65 | 2019-2025 | |
| Verathon INC. | $500.00 | 2022 | |
| Insmed, INC. | $488.43 | 2020-2025 | Arikayce, Brinsupri |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $460.21 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System |
| Lilly USA, LLC | $455.62 | 2020-2025 | Mounjaro, Trulicity, Zepbound |
| Hill-Rom Services, INC | $450.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $441.89 | 2019-2024 | Xarelto |
| Octapharma USA, INC. | $365.72 | 2022-2025 | Panzyga, Octagam Immune Globulin (Human) |
| Inari Medical, INC. | $343.82 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $241.18 | 2019-2025 | Vaxneuvance, Gardasil 9, Capvaxive |
| Novo Nordisk INC | $219.35 | 2019-2025 | Rybelsus, Ozempic |
| Advanced Respiratory, INC | $215.28 | 2020-2021 | |
| Mylan Specialty L.P. | $207.48 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $202.17 | 2025 | Purified Cortrophin Gel |
| Otsuka America Pharmaceutical, INC. | $156.99 | 2019 | |
| Allergan, INC. | $149.68 | 2019-2020 | |
| Astellas Pharma US INC | $131.87 | 2019-2024 | Veozah |
| Exact Sciences Corporation | $128.32 | 2023-2025 | Cologuard Collection Kit |
| Shionogi INC | $126.67 | 2022-2024 | Fetroja |
| Amarin Pharma, INC. | $107.14 | 2019-2020 | |
| Esperion Therapeutics, INC. | $101.37 | 2021-2024 | Nexletol |
| United Therapeutics Corporation | $96.35 | 2021 | |
| Vifor Pharma, INC. | $91.05 | 2024-2025 | Zemaira |
| Veran Medical Technologies, INC. | $89.45 | 2019-2021 | |
| Regeneron Pharmaceuticals, INC. | $81.47 | 2019 | |
| Philips North America LLC | $75.94 | 2019-2023 | |
| Nabriva Therapeutics, Plc | $72.71 | 2022 | |
| Stryker Corporation | $67.71 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $66.17 | 2021-2023 | |
| Harmony Biosciences LLC | $61.43 | 2023-2024 | Wakix |
| E.R. Squibb & Sons, L.L.C. | $59.79 | 2021 | |
| Gilead Sciences, INC. | $59.32 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $56.81 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.91 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $52.64 | 2019-2022 | |
| Optinose US, INC. | $49.84 | 2023 | |
| Circassia INC. | $44.17 | 2019 | |
| Verona Pharma, INC. | $41.52 | 2025 | Ohtuvayre |
| Alnylam Pharmaceuticals INC. | $41.39 | 2023 | Amvuttra |
| Radius Health, INC. | $41.27 | 2020-2024 | Tymlos |
| Csl Behring | $36.63 | 2022 | |
| Covis Pharma Gmbh | $33.90 | 2022 | |
| Liquidia Technologies, INC. | $32.71 | 2025 | Yutrepia |
| Mallinckrodt Hospital Products INC. | $31.93 | 2022 | |
| Melinta Therapeutics, LLC | $30.79 | 2020-2021 | |
| Lundbeck LLC | $29.75 | 2019-2020 | |
| Electromed, INC. | $28.87 | 2021 | |
| Pinnacle Biologics, INC | $24.74 | 2024 | Photofrin |
| Paratek Pharmaceuticals, INC. | $23.11 | 2020 | |
| Shire North American Group INC | $23.04 | 2019 | |
| Daiichi Sankyo INC. | $22.10 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $21.97 | 2022 | |
| Pulmonx Corporation | $21.76 | 2023 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Xeris Pharmaceuticals, INC. | $20.35 | 2021 | |
| Tactile Systems Technology INC | $16.65 | 2022 | |
| Sumitomo Pharma America, INC. | $16.59 | 2025 | Gemtesa |
| Vyera Pharmaceuticals, LLC | $16.48 | 2020 | |
| Medtronic, INC. | $14.86 | 2024 | Minimed 780g |
| Aytu Biopharma, INC. | $13.28 | 2019 | |
| Biogen, INC. | $11.94 | 2019 | |
| Sanofi Pasteur INC. | $11.67 | 2019 |
9 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.